Clinical Report: Changes in Maternal TSH and FT4 Levels Throughout Pregnancy
Overview
This study investigates the relationship between changes in maternal TSH and FT4 levels during pregnancy and the risk of preeclampsia in euthyroid women. Significant increases in TSH combined with decreases in FT4 are associated with higher risks of preeclampsia and related complications.
Background
Preeclampsia is a significant pregnancy complication characterized by hypertension and organ dysfunction, impacting maternal and fetal health. Understanding the role of thyroid function in this context is crucial, as thyroid dysfunction has been linked to adverse pregnancy outcomes. This study aims to clarify whether longitudinal changes in thyroid hormone levels can serve as indicators for preeclampsia risk among women with normal thyroid function.
TSH changes exhibited a J-shaped nonlinear association with preeclampsia risk.
FT4 changes were linearly and negatively associated with preeclampsia risk.
The Complete Decompensation group had the highest risk of preeclampsia at 2.7%.
Population-attributable risk analysis indicated 21.6% of preeclampsia cases were attributable to specific thyroid function patterns.
Sensitivity analyses confirmed the robustness of the findings.
Clinical Implications
Monitoring TSH and FT4 levels throughout pregnancy may provide valuable insights into the risk of preeclampsia, even in women with normal thyroid function. These findings could inform clinical practices regarding prenatal care and risk assessment.
Conclusion
The study highlights the importance of thyroid function changes during pregnancy as potential risk indicators for preeclampsia, suggesting a need for further research in this area.
More than 80% of women who were partially up to date reported a wellness visit in the prior year, suggesting missed opportunities for screening engagement in primary care.
